Judge Noreika invalidates Novartis subsidiary’s patents covering Lutathera (lutetium-177 dotatate) cancer drug, finding all asserted claims invalid under the on-sale bar — clearing a potential path for generic competition.
The Federal Circuit reversed and remanded a district court’s IPR estoppel ruling for the second time, holding that a classification search returning 26,333 results cannot show a prior art reference was “reasonably discoverable,” and that Cardinal IP’s search evidence for a second invalidity ground was tainted by hindsight bias throughout.
In a precedential decision, the Federal Circuit reversed district court estoppel orders that had blocked Valve from using two prior-art grounds at trial, holding that classification searches returning 26,333 results do not establish discovery and that hindsight-infected forward citation searches cannot prove what a 2016 petitioner reasonably could have raised.
The Federal Circuit affirmed denial of a preliminary injunction sought by Boston Scientific to block Stryker’s OptaBlate BVN spine pain device, finding substantial questions about whether Stryker’s product meets the patent’s introducer placement requirements.
Judge Albright denies Acer’s post-trial JMOL motion, upholding a $10.3 million jury verdict for SVV Technology Innovations on LED display technology patents covering gaming monitors.
The U.S. International Trade Commission announced it will review portions of the administrative law judge’s determination that GoTrax and Gyroor infringed Razor USA’s hoverboard patents, with a limited exclusion order and cease-and-desist orders recommended by the ALJ pending Commission review.
A federal judge in Delaware denied Guardant Health’s post-trial motions seeking to overturn or modify the jury’s $83.4 million verdict for willful infringement of University of Washington duplex consensus sequencing patents exclusively licensed to TwinStrand Biosciences.
Judge Gregory Williams of the District of Delaware denied GlaxoSmithKline’s motions to dismiss prosecution laches defenses asserted by Pfizer/BioNTech and Moderna, finding the defendants plausibly alleged that GSK unreasonably delayed patent prosecution for over a decade and then broadened mRNA vaccine claims only after its rivals’ COVID vaccine technology became public.
The Federal Circuit affirmed a PTAB inter partes review finding that claims of Medmix’s fluid-mixing patent (U.S. 9,010,578) are obvious, rejecting the patent owner’s narrow claim construction for ‘at least two ramps’ and upholding the Board’s motivation-to-combine analysis.
Judge Jacqueline Scott Corley of the Northern District of California dismissed TDK Corporation of Japan from a piezoelectric MEMS patent infringement suit, holding that conclusory stream-of-commerce allegations were insufficient to establish personal jurisdiction and that plaintiff lacked a legitimate basis for naming the Japanese parent company as a defendant.
Judge Araceli Martínez-Olguín of the Northern District of California awarded Favored Tech $2,208,115.77 in attorney’s fees under 35 U.S.C. § 285 after finding that P2I Ltd.’s nano-coating patent infringement case was exceptional due to bad faith litigation conduct.
A Delaware federal jury found that TVision Insights did not infringe Nielsen’s patent covering digital-signature technology used to identify audio content for television audience measurement, handing TVision a trial victory in a long-running patent dispute over audience-tracking methods.
A Delaware jury unanimously found that Amgen’s Teneobio subsidiary willfully infringed Harbour Antibodies’ foundational patent on transgenic mouse platforms for generating fully human monoclonal antibodies, awarding $20.2 million in damages that could be trebled to $60.6 million for willfulness.
A Delaware federal jury finds Amgen and its subsidiary Teneobio willfully infringed a foundational patent covering the production of heavy chain-only antibodies in transgenic mice, awarding $20.2 million in damages — the full amount requested by the plaintiffs.
A new PTAB panel — assembled after a conflict-of-interest controversy forced removal of the original APJ — issues a second Final Written Decision finding U.S. Patent No. 9,917,856 unpatentable on obviousness grounds, dealing another blow to Centripetal Networks’ once-$1.9 billion patent assertion against Cisco.
The Federal Circuit affirmed the dismissal of DynaPass’s infringement claim against Bank of America, holding that the claim term ‘receiving the password’ requires the user to submit a pre-combined passcode-and-token password — not submit the two components separately as BofA’s mobile banking app does.
A Virginia federal judge denied Altria Group and NJOY’s motion for a preliminary injunction to halt an ITC patent investigation over vaping device patents, rejecting the companies’ argument that the ITC’s administrative law judge appointment process is unconstitutional.
The Patent Trial and Appeal Board upheld two Zaxcom wireless audio recording patents in back-to-back IPR final written decisions, finding that Academy Award and Emmy Award recognition for the technology defeated RØDE Microphones’ obviousness challenge.
Judge Jennifer L. Hall of the District of Delaware denied Ferring’s post-trial motions, preserving a $25 million jury verdict in favor of Finch Therapeutics and the University of Minnesota on three fecal microbiota transplant patents covering Ferring’s Rebyota product.
The Patent Trial and Appeal Board invalidated all claims of Inari Medical’s U.S. Patent No. 11,554,005 covering a system for treating embolism, finding the claims anticipated by and obvious over prior art in a Final Written Decision from IPR2025-00289.
The Patent Trial and Appeal Board issued split decisions in Stratasys Inc.’s ongoing patent dispute with Chinese 3D-printing rival Bambu Lab and its parent Shenzhen Tuozhu Technology, invalidating claims in one Stratasys patent while upholding another covering networked 3D printing.
The Federal Circuit affirmed the PTAB’s obviousness rejection of a pro se inventor’s patent application for an automated kitchen system, holding that substantial evidence supported the motivation to combine the cited prior art references.
A New Jersey federal court allowed WinView’s direct patent infringement claims against FanDuel to proceed, while dismissing with prejudice the indirect and willful infringement counts for failure to plead pre-suit knowledge — the same result previously reached in a parallel WinView case against DraftKings.
The PTAB issues a Final Written Decision upholding Yangtze Memory Technologies’ U.S. patent on electrostatic discharge bus architecture, rejecting Micron’s invalidity challenge — and earlier rejecting Micron’s novel argument that national security grounds should shield the IPR from Board review.
The Federal Circuit reversed PTAB’s finding that Sonos’s IPR challenge anticipated Google’s hotword-detection coordination patents, holding the Board’s key factual finding lacked substantial evidence.
Judge Edward Chen of the N.D. Cal. granted Apple summary judgment, holding that Neonode’s foundational swipe gesture patent (U.S. 8,095,879) is invalid for lack of written description under 35 U.S.C. § 112.
The Federal Circuit affirmed that claim 18 of Purdue Pharma’s patent on abuse-deterrent OxyContin — covering tablets heated in a coating pan — was obvious in light of prior German pharmaceutical art, ending a litigation effort by Purdue’s successor Knoa Pharma.
Case Overview Shoals Technologies Group, LLC v. Voltage, LLC and Ningbo Voltage Smart Production Co., No. 1:25-cv-00026 (M.D.N.C. June 5,
The Federal Circuit affirmed PTAB decisions finding all challenged claims of three patents related to lost-computer recovery screens unpatentable as obvious, rejecting challenges to IPR institution and claim construction.
The Federal Circuit affirmed that Nexus Pharmaceuticals’ generic minocycline product infringes Melinta’s patent covering a magnesium-containing antibiotic formulation that reduces injection-site hemolysis.
The U.S. International Trade Commission has instituted a Section 337 investigation (337-TA-1504) into allegations that Amazon’s Echo speakers, Echo Show displays, and Fire TV devices infringe five AI voice technology patents owned by Cerence Operating Company.
A unanimous Supreme Court reversed the Federal Circuit and ended Amarin’s induced infringement suit against Hikma’s skinny-label generic of Vascepa, holding that anodyne marketing references to the branded drug do not plausibly allege that a generic maker actively encouraged infringing uses.
The Federal Circuit vacated an $11.5 million patent infringement verdict against ecobee, holding that a single-question verdict form covering four patents was improper and that the jury was not properly instructed on the abstract idea under Alice step two.
The Federal Circuit reversed a PTAB decision that had upheld claims of a spinal implant patent, finding the Board misconstrued the term ‘complementary with one another’ and that the claims are obvious under the correct construction.
NEC Corporation v. Anker Innovations Technology Co., Ltd. et al, No. 2:24-CV-00720-JRG (E.D. Tex. June 4, 2026) (Gilstrap, J.) Download
The UPC Court of Appeal ruled that the Unified Patent Court can accept jurisdiction over patent infringement in non-member states like the UK, but overturned a Mannheim injunction on substantive grounds — establishing a three-category framework for managing long-arm claims.
A Northern District of California court denied Google’s motion to dismiss a direct infringement claim over containerization technology patents, finding that whether Google Kubernetes Engine and Cloud Run satisfy the patent’s filtering requirement must await claim construction.
A Texas federal court construed ten disputed terms across five cybersecurity patents asserted by Arizona State University’s commercialization arm against CrowdStrike, largely adopting plain-and-ordinary-meaning constructions and rejecting CrowdStrike’s bids to narrow the claims.
The District of Delaware denied Align Technology’s bid to invalidate two intra-oral dental scanning patents under Section 101, finding the claims directed to specific technological improvements rather than abstract ideas, while dismissing willful and indirect infringement claims against both Align and Medit for failure to adequately plead pre-suit knowledge.
The Federal Circuit vacated the PTAB’s decision upholding an e-learning patent, finding the Board improperly dismissed expert testimony on obviousness as ‘conclusory’ when it addressed a simple design choice of reordering two steps.
A Massachusetts federal jury found that Abiomed’s Impella heart pump devices do not infringe Maquet Cardiovascular’s intravascular blood pump patents, ending a long-running patent dispute between the Johnson & Johnson and Getinge subsidiaries.
A federal judge in San Diego granted Intuit summary judgment of noninfringement, finding that TurboTax’s co-browsing feature does not infringe Samesurf’s U.S. Patent No. 9,483,448 covering synchronized web browsing technology.
The Federal Circuit affirmed judgment as a matter of law that DISH Network’s AutoHop commercial-skipping feature does not infringe ClearPlay’s content-filtering patents, finding that AutoHop uses categorical on/off settings rather than directly disabling individual navigation objects.
The Federal Circuit affirmed the PTAB’s finding that all 17 claims of Pictometry’s patent on measuring roofs from aerial imagery are unpatentable as obvious over prior art combining roof-measurement and marker-locking references.
An Eastern District of Texas jury awarded SK nexilis $3.3 million after finding that Solus Advanced Materials and its Volta Energy subsidiaries willfully infringed five patents covering electrolytic copper foil manufacturing methods used in electric vehicle batteries.
The Federal Circuit affirmed the PTAB’s finding that all claims of a synchronized-browsing patent were unpatentable as obvious, rejecting the patent holder’s bid to narrowly construe the key claim term “web browsing interaction data.”
The Federal Circuit affirmed that Lupin’s generic tolvaptan manufacturing process does not infringe Otsuka’s patents and that certain synthesis method claims are obvious, clearing the way for a generic version of the kidney disease drug JYNARQUE®.
In a patent litigation over cancer diagnostics, a federal court adopted sanctions totaling nearly $3 million against Quinn Emanuel and five named attorneys, plus a $100,000 punitive sanction and mandatory ethics training, for deliberately misleading the court about an expert’s access to embargoed clinical trial data.
The Federal Circuit reversed a dismissal for lack of standing, holding that a patent owner who grants an exclusive license but retains the right to sue, a sublicensing veto, and royalty interests retains a sufficient exclusionary right for Article III standing.
In a companion case to ALM Holding v. Zydex, the Federal Circuit held that Medtronic Ireland retained Article III standing to assert patent infringement counterclaims despite licensing exclusive rights to an affiliate, because it kept the right to sue, sublicensing veto, and royalty interests.